Our Blog:

30 years of cell culture excellence

Author: Biological Industries

Biological Industries Announces New Agreement with Mediatech, Inc., a Corning Subsidiary

Co-branding agreement of NutriStem® hPSC XF Medium for pluripotent stem cell culture to be commercialized by Corning June 22, 2016 CROMWELL, Conn. & KIBBUTZ BEIT HAEMEK, Israel–(BUSINESS WIRE)–Biological Industries (“BI”) announced today a co-branding agreement with Corning Incorporated’s subsidiary, Mediatech, Inc., which will enable cell therapy, research, and manufacturing organizations around the world to purchase the innovative, xeno-free NutriStem® human pluripotent stem cell (“hPSC”) medium in conjunction with Corning’s existing portfolio of stem cell-focused technologies. Before the end of this year, Corning and BI will launch a jointly-branded NutriStem&reg hPSC XF Medium, which will continue to be manufactured by...

Read More

Biological Industries to Participate at the ISSCR Annual Meeting 2016

Announces the launch of new xeno-free endothelial cell culture system suitable for clinical applications June 21, 2016 CROMWELL, Conn. & KIBBUTZ BEIT HAEMEK, Israel–(BUSINESS WIRE)–Biological Industries USA (“BI USA”; www.bioind.com), the US commercialization division of Biological Industries, a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, and custom media manufacturing services, will have a major presence at the International Society for Stem Cell Research (ISSCR) Annual Meeting, June 22-25 in San Francisco. “This year’s ISSCR meeting, co-sponsored by CIRM, promises to be the best one yet,” commented Tanya Potcova, CEO of BI USA....

Read More

BI Announces Poster Presentation at International Society for Cell Therapy Annual Meeting in Singapore

Dr. Mira Genser-Nir to Present Poster at ISCT 2016 on Novel Set of Serum-Free, Xeno-Free Differentiation Media May 23, 2016 KIBBUTZ BEIT HAEMEK, Israel & CROMWELL, Conn.–(BUSINESS WIRE)–Biological Industries (“BI”; www.bioind.com), a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, and custom media manufacturing services, is participating and making a poster presentation at ISCT 2016, the annual meeting of the International Society for Cellular Therapy, 25-28 May, in Singapore. The poster presentation, “A Novel Set of Serum-Free, Xeno-Free Differentiation Media for Adipogenesis, Osteogenesis and Chondrogenesis of Human Mesenchymal Stem Cells from Various Tissue...

Read More

European Field Application Specialist for Stem Cell Products

Biological Industries (BI) is very pleased to announce the appointment of Suzanne Badoux as our new European Field Application Specialist focusing on our technically supporting our stem cell products and services. Along with the launch of Biological Industries USA (BI USA), a new division headquartered in the United States, the appointment of an European Field Application Specialist is part of BI planned growth strategy, and provides technical support for scientists in Europe. Suzanne gained her MSc in Medical Biology at UNIL, The University of Lausanne, Switzerland She has also now completed an intensive training at the BI facility in Beit Haemek, Israel, where she spent a total of 3 months in  production, R&D, customer services and Marketing departments. We are very confident that Suzanne’s appointment will help researchers around Europe have in-person support, and easy, direct access to our dedicated technical experts and collaborations with our R&D scientists....

Read More

Biological Industries Expands to the United States

Biological Industries expands to the United States, providing innovative research technology to the U.S. life sciences market CROMWELL, CT, USA & Kibbutz Beit Haemek, Israel, October 15, 2015 – Biological Industries (http://www.bioind.com/), a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, and custom media manufacturing services, announced today it will be expanding its operations to the United States. The company, which prides itself with over 30 years of cell culture media development expertise, state-of-the-art cGMP facilities, and key partnerships with some of the worlds’ leading scientists, will launch Biological Industries USA, Inc. (BI-USA)...

Read More

Follow Us

Subscribe